High-tech medical diagnostics AI

Bridging the gap between patients and timely medical intervention.

Early detection saves lives · Disease control and eradication

The rises.AI platform, many algorithms, many products — deployed across government screening programmes, hospital diagnostics, and joint medical research, so clinicians can serve patients with efficacy and at scale.

AI Assist
Validated & Recognised by
ICMR Indian Council of Medical Research
Atal Innovation Mission AIM NITI Aayog
IRIA - Indian Radiological And Imaging Association
NHS
stop TB
The Platform rises.AI

One platform. Many products and Solutions.

The rises.AI platform holds the algorithms. Algorithms combine into products focused on specific diseases. Products combine into solutions for real-world use cases — sold and deployed through three business lines.

01

Platform

Deep Learning · Machine Learning · GenAI models trained on medical imaging and clinical dataset — X-rays, CT, mammography and more. Solution elements include Rises CDS and Rises GenAI Guru.

02

Products

Disease focused field validated products e.g. Rises ThorDx™ for AI based detection on CXR for Pulmonary Conditions, Rises MammoDx™ for breast cancer 2D mammography.

03

Solutions

Products bundled for an use case — public-health screening, women’s health — screening to survivorship, occupational and climate-linked health risk.

Business Lines

Three lines. One platform.

Each line has its own customer, its own commercial model, and its own way of putting rises.AI to work.

Rises TB CXR AI MMU
Line 1 — Preventive Screening

Public-health screening, at population scale

"Early detection saves lives."  ·  "Disease control and eradication."

We design and provide the technology; operations are typically run by Government, social-impact organisations, NGOs or diagnostic companies — funded by Government, CSR and corporate-support pools.

  • NCD screening (e.g. breast, cervical, lung cancer) — AI-assisted triage on mobile units and partner sites, funded through CSR, corporate-support partnerships, government health programmes and philanthropy.
  • CD screening (e.g. TB, pneumonia) — AI-assisted chest X-ray on mobile units. In India, TB control is funded by Government and CSR; the patient doesn't pay directly, so the commercial play is large screening orders, not large investments.
Clientele: Government health departments, CSR-sponsored/corporate procurement, channel and referral partners — including hospital chains.
Charging model: Capex (MMU/setup) → recurring licence + AMC → SaaS pay-per-use, via bulk institutional orders.
Validated entry point: rises.AI TB solution validated by ICMR and the Central TB Division, MoHFW, with further certification underway for mass deployment and OEM licensing.
Line 2 — Medical Diagnostics

AI enabling hospital departments & AI framework for dignostic chains

Hospital and diagnostic-chain market

AI built via co-creation, with a B2B or medical-service commercial model — enterprise-grade building blocks tailored to a hospital's protocol, workflow and use case.

  • Co-creation, not just sales. The hospital or diagnostic chain is a co-builder of the solution; payment can be a hybrid of strategic investment and client fee, with the balance supported by investor funding.
  • Workflow automation — PACS/RIS integration, AI-based reporting, treatment-response analytics.
  • Distribution targets — imaging-AI platforms, SaMD/OEM routes (VisionXray), hyperscaler health clouds (AWS, GCP, Azure), and tele-radiology partners.
Clientele: Hospitals & diagnostic chains, strategic investors, device/software OEMs, enterprise clients under an MSA/SoW.
Flexible charging model: Per-SoW project fees, milestone billing, SaaS pay-per-use once live, value-based B2B pricing.

Are you a hospital or diagnostic chain open to co-creation? Let's talk →

Rises CDS powered by rises.AI for insigts and accuracris of dignostics
Rises CDS powered by rises.AI for medical research
Line 3 — Joint Research

Collaborative R&D that ships a product, not just a paper

With medical institutions, the NHS and healthcare researchers

Good analogue: drug-discovery R&D — the resulting product can generate revenue for more than a decade.

  • Funded by grants, Government innovation programmes, VC funding and dedicated AI clinical-validation budgets.
  • Partners: medical institutes, hospitals & cancer centres, NHS & international health systems, medical AI research groups and clinical investigators.
  • What we contribute: platform algorithms adaptable to the research question, large datasets with labelling/bias management, clinical-validation infrastructure, and a concept-to-productisation pipeline with joint IP where appropriate.
  • Track record with Cancer Hospital TMC Mumbai, DMIHER Wardha, and VY Hospital Raipur — under mandates like the National Cancer Grid (India) and equivalent bodies in the UK, USA and UAE.
Who pays: Government grants (e.g. GCI–BIRAC), challenge funds, private funding agencies, VCs, co-funding hospitals/pharma.
Charging model: Milestone-based grant drawdowns via the collaborating institute — funding-based, not patient- or unit-based.
The long tail: grant/VC-funded development today becomes licensable IP and products that can pay out for years.

Medical institute interested in a joint grant or study? Reach out →

Platform and Products

Platform-based products

Each product is an algorithm combination from the rises.AI platform, focused on a specific disease or clinical workflow — spanning detection, response assessment and prognostics, as part of our Clinical Decision Support solution & Rises GenAI Guru.

Rises CDS report UI
Clinical Decision Support

Rises CDS

A medical AI assistant providing three-layered support: automated disease detection on first visit, disease-progression analytics on follow-up, and prognostic, predictive patient profiling — with fully customisable automated reporting.

Rises CDS powered by rises.AI GenAI Guru
Conversational AI

Rises GenAI Guru

RAG- and LLM-based conversational AI plus fine-tuned small language models, built for healthcare — supporting patient-centric clinical decisions, treatment tracking and prognostic assessment across medical imaging and multi-modal data.

Rises ThorDx
Pulmonary & TB

Rises ThorDx™

AI for pulmonary conditions on chest X-ray — TB plus 20+ abnormalities (pneumonia, effusion, nodules, emphysema, fibrosis, silicosis and more). Edge-capable on a Mobile Medical Unit, syncing to cloud when connected.

Rises mammogram with BI-RADS overlay
◦ Breast Cancer Focus Women's Health

Rises MammoDx™

Breast-cancer-first women's health AI — detection and classification with BI-RADS scoring across 2D mammography, 3D tomosynthesis, CECT, ultrasound and MRI, from screening through treatment-response and onco lifecycle management.

Solutions

Where use-case-focused products come together

To solve specific problems — from mobile screening through to hospital-grade diagnosis.

Rises MammDx MMU
◦ Breast Cancer Awareness

Women's Health — Screening MMU

From mobile screening to hospital connect

Screening : breast-cancer-first women's health AI — detection and classification with BI-RADS scoring across 2D mammography using Rises MammoDx. The case is referred to hospital for further investigation & treatment.

  • Hub & Spoke model — every suspect case is referred to the appropriate hospital for further investigation. The multimodal MMU can extend to other women's-health-related onco screening, including cervical and lung cancer.
Rises occupational/environmental health screening

Climate & Occupational Health Impact

Screening for four primary, climate-linked conditions

  • TB on CXR — infections and communicable disease
  • Silicosis — occupational hazard, CXR + pulmonary function test
  • Cardiovascular abnormality detection on ECG and CXR
  • Lung cancer on CXR, with referral for LDCT confirmation
Rises Accident and Emmergency

Accident & emergency

Detection tech with fast turnaround

  • Abdominal trauma blunt injuries on CT scan
  • Chest blunt injuries lncluding ribcage facture and pulmonary impact
  • Bone factures
Rises NeuroDx and Onco solutions

Oncology & surgery custom build solutions

Cocreation framework for Hospital depts, diagnostic area focus

  • Ingisgnts, accuracies and workflow optimization.
  • Integrable with workflows and existing systems
  • Lung & breast cancer, head & neck onco, neurosurgery
  • Multimodal models X-ray, LD CT, 2D/3D mammography, CECT, MRI
Partners & Collaborators

Build the next line of rises.AI with us

We're actively looking for hospitals and diagnostic chains ready to co-create, medical institutes ready to pursue joint grants, and investors who want in on a de-risked, multi-line healthcare AI model.

Hospitals & Diagnostic Chains

Co-create a workflow-specific solution with us — from breast oncology to neurosurgery assist to A&E triage. You're a co-builder, not just a customer, with a hybrid payment model.

Propose a co-creation

Medical Institutes & Researchers

Joint research that ships a product — clinical validation, large datasets, and a concept-to-productisation pipeline, with joint IP structures where appropriate.

Discuss a joint grant

Investors & Strategic Partners

Three strong revenue lines, institutional payers, and a validated proof point — innovation-driven and focused, on the rises.AI platform-based SaaS B2B/B2G model. Ask us for the revenue model and investor storyboard.

Request the investor deck
Highlights

Recognised by the institutions that matter

NITI Aayog, ICMR, TCS NASSCOM, the Stop TB Partnership, and 25+ more moments from our journey so far — now with the full story, on one page.

View all highlights →
About rises.AI

Founded to bring high-tech diagnostics within reach

Rises

Rises Analytics Solutions Pvt Ltd was founded with the urge to conquer goals that make a meaningful impact on people's lives through the application of innovative technologies — bringing high-tech diagnostics within reach of clinicians and patients everywhere. Incubated at the AIC-LMCP Foundation under the Atal Innovation Mission (NITI Aayog), with further support from IITB SINE and T-Hub Hyderabad.

Ajit Deshpande

Ajit Deshpande

Founder & CEO. MCA NIT Raipur, 30 years in software industry, techno management & leadership at HSBC, TCS, Sungard, SAS, Veritas & C-DAC. Was based in California for 5 years.
Narayana Darapaneni PhD

Narayana Darapaneni PhD.

Co-Founder & Chief Data Scientist, PhD, Paris VI. AI Specialist, 20 years in software industry - worked for CRL, TCS and startups. Research publications & academics.
Kieran Ebbs

Kieran Ebbs

CRO, Based in London, UK. Strong tech background with entrepreneurial skills, ex CIO Banks in UK, tech leadership in USA
Gouri Deshpande

Gouri Deshpande

Co-Founder & Director, BS MS Biology . women entrepreneur, Handling proposals, communication new connects & business relations.
Talk to us

Let's build the next chapter together

Whether you're a government health programme, a hospital ready to co-create, a medical institute pursuing a joint grant, or an investor — we'd like to hear from you.

For partners, clients & investors

Government health departments, CSR teams, hospitals, diagnostic chains, OEMs, medical-service providers, medical institutes and investors — one inbox, fast response.

Email: hello@rises.io

hello@rises.io

Prefer WhatsApp?

Message us directly on WhatsApp for a quick conversation — co-creation proposals, grant discussions or investor queries all welcome.

WhatsApp: +91 98225 74086

Chat on WhatsApp